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Supplemental parenteral nutrition (SPN) is used in a step-up approach when full enteral support is contraindicated
or fails to reach caloric targets. Recent nutrition guidelines present divergent advices regarding timing of SPN in
critically ill patients ranging from early SPN (<48 h after admission; EPN) to postponing initiation of SPN until
day 8 after Intensive Care Unit (ICU) admission (LPN). This systematic review summarizes results of prospective
studies among adult ICU patients addressing the best timing of (supplemental) parenteral nutrition (S)PN. A
structured PubMed search was conducted to identify eligible articles. Articles were screened and selected using
predetermined criteria and appraised for relevance and validity. After critical appraisal, four randomized controlled
trials (RCTs) and two prospective observational studies remained. One RCT found a higher percentage of alive discharge
from the ICU at day 8 in the LPN group compared to EPN group (p = 0.007) but no differences in ICU and in-hospital
mortality. None of the other RCTs found differences in ICU or in-hospital mortality rates. Contradicting or divergent
results on other secondary outcomes were found for ICU length of stay, hospital length of stay, infection rates,
nutrition targets, duration of mechanical ventilation, glucose control, duration of renal replacement therapy,
muscle wasting and fat loss. Although the heterogeneity in quality and design of relevant studies precludes firm
conclusions, it is reasonable to assume that in adult critically ill patients, there are no clinically relevant benefits of
EPN compared with LPN with respect to morbidity or mortality end points, when full enteral support is contraindicated
or fails to reach caloric targets. However, considering that infectious morbidity and resolution of organ failure may be
negatively affected through mechanisms not yet clearly understood and acquisition costs of parenteral nutrition are
higher, the early administration of parenteral nutrition cannot be recommended.
Keywords: Critically ill patient; ICU; Parenteral nutrition; Supplemental parenteral nutrition; Timing; Mortality; Nutritional
support; Mechanical ventilation; Renal replacement therapy; Muscle wastingReview
Introduction
Nutritional support in the intensive care unit (ICU) is
highly debated as critically ill patients are frequently
hypermetabolic, catabolic and at risk of both underfeed-
ing and overfeeding. Enteral nutrition (EN) is frequently
recommended over parenteral nutrition (PN) as it may
preserve gut mucosal barrier function [1,2] and has been
shown to demonstrate beneficial effects on (gut) immun-
ity. The current literature shows evidence in favour of
early enteral nutrition (EEN) commenced within 24 to
48 h after ICU admission [3]. EEN is associated with* Correspondence: zantena@zgv.nl
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in any medium, provided the original work is pdecreased morbidity (lower infection rates, better wound
healing, decreased mechanical ventilation duration, ICU
and hospital length of stay and duration of recovery) [4]
and even reduced mortality [5]. Therefore, EN is the
preferred route over parenteral nutrition whenever EN is
possible.
Achieving caloric targets with EN may be challenging
in the critically ill. A caloric deficit frequently occurs
due to slow intake progression, unnecessary stoppages,
delayed gastric emptying, enteral feed intolerance and
delays in post-pyloric feeding tube placement [6]. The
cumulative deficit or caloric debt has been reported to
be associated with adverse clinical outcomes. Villet and
co-workers showed that delayed initiation of feeding
resulted in a marked cumulative energy debt during
the first week after ICU admission associated with anOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Bost et al. Annals of Intensive Care 2014, 4:31 Page 2 of 13
http://www.annalsofintensivecare.com/content/4/1/31increase in infectious complications, days of mechan-
ical ventilation and length of ICU stay. However, pos-
sibly not only energy deficit but also deficient protein
intake may be relevant and is suggested to play a role
in outcome [7,8].
In recent guidelines, controversy regarding the timing of
supplemental PN (SPN) in ICU patients was found [7-9].
The European Society for Clinical Nutrition and Metabol-
ism (ESPEN) guidelines recommend the addition of SPN
within 24 to 48 h in patients who are expected to be
intolerant to EN within 72 h of admission [7], whereas the
American Society for Parenteral and Enteral Nutrition
(ASPEN) recommends postponing the initiation of PN
until day 8 after ICU admission [9].
SPN is used in a step-up approach when full enteral
support is not possible or fails to reach caloric targets.
This review based on a systematic literature review sum-
marizes results of trials reported in ICU patients ad-
dressing the optimal timing of (S)PN.Methods
Search strategy
A search was conducted on 4 November 2013 in PubMed
to identify all published studies reporting on trials ad-
dressing the timing of (supplemental) parenteral nutrition
in critically ill adult patients, combining synonyms for do-
main and determinants: (‘critically ill’ OR ‘Intensive Care’
OR ‘ICU’) AND ((parenteral OR intravenous OR i.v.)
AND (feeding OR feedings OR nutrition OR pharmaco-
nutrition)). No limits were used.
Duplicates were excluded and remaining references
were screened using titles, abstracts and subsequently
full texts. Inclusion criteria were compatible domains
and determinants and a full text available in Dutch,Table 1 Critical appraisal of selected studies
Study Criti
Relevance
Domain Determinant Randomization Blin
Allocation Similarity
Bauer 2000 [11] + + + + +
Cahill 2011 [12] + + x x −
Casaer 2011 [13] + + + + +
Doig 2013 [14] + + + + +
Heidegger
2013 [15]
+ + + + +
Kutsogiannis
2011 [16]
+ + x x −
Specification per item: Domain: critically ill adult patients on the ICU? + = yes, − = n
concealed treatment allocation? + = yes, − = no; similarity subgroups in baseline cha
Standardization: + = yes, − = no. Missing data: percentage? + = <5%, +/− = 10%
percentage? + = <5%, +/− = 10%, − = >10%; reason? + = reason given, +/− = n
analysis, intention to treat analysis; x, not applicable.English or German languages. Exclusion criteria were
animal studies, nonadult studies, systematic reviews,
meta-analyses, opinion papers, case reports, and evalu-
ation studies of guidelines. References were reviewed for
additional studies.Critical appraisal
Using standardized criteria [10], all selected articles were
appraised on relevance and validity (Table 1). Limita-
tions in studies were evaluated, selected from letters to
editors and reported per study.
Results are presented as primary end points per study
and grouped by relevant end points. No recalculations of
statistics of original results were performed.Results
The search strategy yielded a total of 3,520 articles
(Figure 1). After the removal of duplicates and screen-
ing on predefined criteria, six articles remained (Table 2).
Four studies were randomized controlled trials (RCTs)
[11,13-15], and two articles were prospective observational
studies [12,16].
Baseline characteristics and feeding details of patients
included in the studies are shown in Table 3. In the
study by Kutsogiannis significant differences between
study groups in baseline age (mean age in the EN group
58.4 versus 62.3 years in the EPN group and 56.4 years
in the LPN group) and body mass index (BMI) (mean
BMI in the EN group 27.2 versus 24.5 kg/m2 in the EPN
group and 27.0 kg/m2 in the LPN group) were observed
[16]. In two studies [12,16], significant differences in
baseline admission diagnosis and number of days in hos-
pital before ICU admission were found.cal appraisal items
Validity
ding Standardization Missing data Follow-up
% Reason % Reason ITT analysis
+ - - − + +
− - - - - −
/− + - - - - +
/− + + + + − +
/− + - - +/− +/− +
− - - - - −
o. Determinant: parenteral nutrition? + = with PN, − = no PN. Randomization:
racteristics? + = yes, − = no. Blinding: + = yes, +/− = partial, − = no.
, − = >10%; reason? + = reason given, − = reason not given. Follow-up:
ot all reasons given, − = reason not given; ITT analysis? + = yes, − = no. ITT
Figure 1 Flow chart of search strategy and selection of articles.
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lected studies. Furthermore, in Tables 5, 6, 7, 8 and 9,
the categorized end points are shown for mortality, ICU
and hospital length of stay, infections, nutrition targets,
mechanical ventilation, glucose control, renal replace-
ment therapy, muscle wasting and fat loss.
Mortality
Results are shown in Tables 4 and 5. Casaer [13] re-
ported a higher percentage of alive discharge from ICU
after day 8 in the LPN group compared to EPN (p =
0.007) but no difference in ICU and in-hospital mortal-
ity. None of the other RCTs [11,14,15] observed differ-
ences in ICU or in-hospital mortality rates. Even after a
follow-up of 2 years no mortality differences were found.
Kutsogiannis [16] found a higher mortality rate in
LPN compared to EN, and the rate of patients dis-
charged alive from hospital was lower in the group that
received SPN compared to EN. However, in this study,no mortality analysis was performed comparing EPN
and LPN.
ICU length of stay
Results are shown in Tables 4 and 6. All studies [11-16]
examined ICU length of stay and hospital length of stay
resulting in contradictory results. In three studies [11,14,15],
there was no difference in ICU length of stay among all
study groups. The other three studies reported results that
are more difficult to interpret. Casaer reported an increased
length of stay in the ICU in the EPN group compared to
LPN (median 4 versus 3 days, respectively) [13]. Cahill and
Kutsogiannis found a shorter stay in the EN group, com-
pared to the PN groups. However, no analysis was per-
formed comparing EPN and LPN [12,16].
Hospital length of stay
Results are shown in Tables 4 and 6. Hospital length of
stay was significantly prolonged in the EPN group
Table 2 Study characteristics





Control group (n) Third group (n)
Bauer 2000 [11] RCT 120 Mixed (exclusion
of elective surgery)
EN + EPN for 4 to
7 days (60)
EN + placebo for 4
to 7 days (60)
x
Cahill 2011 [12] Prospective
observational
study
703 Medical EN + EPN <48 h of
admission (83)
EN >48 h of admission +
no PN (541)
EN + LPN both >48 h
of admission (79)
Casaer 2011 [13] RCT 4,640 Almost 90% surgical
patients (58.5%
admitted electively)
LPN ≥8 days of
admission (2,328)
EPN <48 h of admission
(2,312)
x
Doig 2013 [14] RCT 1,372 Mixed EPN <24 h of
admission (686)
Pragmatic standard care:
unfed for 2 to 5 days (686)
x
Heidegger 2013 [15] RCT 305 Mixed EN + LPN >3 days
of admission (153)
EN at day 1 (152) x
Kutsogiannis 2011 [16] Prospective
observational
study
2,920 Mixed EN <48 h of
admission (2,562)
EN + EPN both <48 h
of admission (188)
EN <48 h of admission +
LPN >48 h of admission (170)
N, number of patients; RCT, randomized control trial; EN, early enteral nutrition; EPN, early parenteral nutrition; x, not applicable; h, hours; LPN, late parenteral
nutrition. NB: studies used different definitions for EPN, LPN and EN.
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[13]. However, Bauer [11] found a significantly shorter
hospital length of stay in the EPN group. Both Cahill
[12] and Kutsogiannis [12,16] found a shorter length of stay
in the hospital in patients not receiving any form of PN.
They did not compare EPN with LPN. In the other studies,
there was no difference in hospital length of stay [14,15].
Infections
Results are shown in Tables 4 and 7. Rates of nosoco-
mial infections were higher in patients receiving EPN in
the study by Casaer compared to LPN (p = 0.008) [13].
Heidegger showed significantly lower infection rates in
the PN group (27% [41/153]) compared with EN (38%
[58/152]) (hazard ratio (HR) 0.65 (95% CI 0.43 to 0.97);
p = 0.0338) [15]. In addition, the number of antibiotic
days was found significantly less in the PN group. How-
ever, Heidegger reported data on new infections after
day 9, whereas randomization took place after day 3.
SPN was provided on day 4, and the SPN group had
more total infectious events between day 4 and day 8
(34% [52/153] versus 28% [43/152]). Total infections
between day 4 and day 28 are similar (114/153 versus
100/152) and nonsignificantly different [17-19].
No differences were found in infection rates in pa-
tients receiving EPN in other studies [11,14].
Nutrition targets
Results are shown in Table 8. The studies by Cahill
and Kutsogiannis found a more adequate intake of cal-
ories in the EPN group (74.1% and 81.2%, respectively;
p < 0.0001) compared to the LPN group (57.4% and
64.3%, respectively; p < 0.0001) [12,16]. Similar results
were found when addressing the adequacy of proteinintake (71.5% and 80.1%, respectively, in the EPN
group compared to 53.2% and 59.9%, respectively, in
the LPN group; p < 0.0001). Heidegger [15] observed a
higher rate of patients reaching their calculated energy
target in the PN group compared to the EN group
(mean energy delivery as percentage of target was
103% and 77%, respectively; p < 0.0001).
Mechanical ventilation
Results are shown in Table 9. Duration of mechanical
ventilation data showed divergent results among studies.
When EN in combination with EPN is compared to EN
with a placebo, no differences were found [11], but com-
paring EPN with standard care showed a shorter dur-
ation of mechanical ventilation (0.47 days) in favour of
EPN (p = 0.01) [14]. In contrast, in LPN patients, Casaer
reported a relative reduction of mechanical ventilation
duration (9.7%) among patients requiring ≥2 days of
mechanical ventilation compared with EPN [13].
LPN was associated with a longer duration of mechan-
ical ventilation in both observational studies when com-
pared with EN (18.2 versus 9.3 median days; p < 0.001
[12] and 14.5 versus 8.4 median days; p = 0.007 [16]).
However, they did not compare EPN and LPN. Further-
more, the study by Heidegger showed no differences in
mechanical ventilation duration comparing LPN to EN
(mean 153 versus 166 h; p = 0.2912 [15]).
Renal replacement therapy
Results are shown in Table 9. Casaer [13] found a signifi-
cant shorter duration of renal replacement therapy (RRT)
among patients on LPN compared with EPN (median 7
versus 10 days, p = 0.008). Other studies investigating RRT
duration did not find significant differences [11,15].
Table 3 Baseline characteristics
Baseline
characteristics
Study Units Study arms Significance
of resultsEPN LPN EN
Age Bauer 2000 [11] Years; mean ± SD 53 ± 18 x 55 ± 18 p= ns
Cahill 2011 [12] 64 ± 15.7 62.8 ± 16.3 59.3 ± 16.8 p= 0.095
Casaer 2011 [13] 64 ± 14 64 ± 15 x p= 0.53
Doig 2013 [14] 68.4 ± 15.1 x 68.6 ± 14.3 NR
Heidegger 2013 [15] x 61 ± 16 60 ± 16 NR
Kutsogiannis 2011 [16] 62.3 ± 17.9 56.4 ± 17.5 58.4 ± 17.9 p= 0.02^
Gender Bauer 2000 [11] Male sex; no (%) 40 (66.7) x 42 (70) p= ns
Cahill 2011 [12] 54 (65.1) 54 (68.4) 303 (56) p= 0.13
Casaer 2011 [13] 1,486 (64.3) 1,486 (63.8) x p= 0.75
Doig 2013 [14] 400 (58.7) x 420 (61.6) NR
Heidegger 2013 [15] x 110 (72) 105 (69%) NR
Kutsogiannis 2011 [16] 121 (64.4) 105 (61.8) 1,563 (61.0) p= 0.66
BMI Bauer 2000 [11] kg/m2; mean ± SD 26 ± 5 x 26 ± 5 p= ns
Cahill 2011 [12] kg/m2; mean ± SD 26.1 ± 5.3 26.8 ± 5.6 27.4 ± 7.3 p= 0.28
<25 kg/m2; no (%) 41 (49.4) 32 (40.5) 225 (41.6) p= 0.054*
25 to 30 kg/m2; no (%) 26 (31.3) 25 (31.7) 166 (31.3)
>30 kg/m2; no (%) 16 (19.3) 22 (27.8) 140 (25.9)
Casaer 2011 [13] <25 kg/m2; no (%) 988 (42.7%) 1,031 (44.2%) x p= 0.34
25 to 30 kg/m2; no (%) 852 (36.9) 864 (37.1) x
>30 kg/m2; no (%) 472 (20.4) 433 (18.6) x
Doig 2013 [14] kg/m2; mean ± SD 27.9 ± 6.8 x 28.5 ± 6.9 NR
>30 kg/m2; no (%) 190 (27.9) x 224 (32.8)
<18.5 kg/m2; no (%) 26 (3.8) x 20 (2.9)
Heidegger 2013 [15] kg/m2; mean ± SD x 25.4 ± 3.9 26.4 ± 4.6 NR
Kutsogiannis 2011 [16] kg/m2; mean ± SD 24.5 ± 4.7 27.0 ± 6.9 27. 2 ± 7.0 p< 0.0001^
<25 kg/m2; no (%) 120 (63.8) 74 (43.5) 1,143 (44.6) p< 0.0003^
25 to 30 kg/m2; no (%) 47 (25.0) 53 (31.6) 756 (29.7)
>30 kg/m2; no (%) 21 (11.1) 41 (24.1) 649 (25.3)
Severity of illness Bauer 2000 [11] SAPS II score; mean ± SD 43 ± 14 x 41 ± 13 p= ns
Cahill 2011 [12] APACHE II score; mean ± SD 25.2 ± 8.5 24.9 ± 8.4 24.3 ± 8.5 p= 0.902
Casaer 2011 [13] APACHE II score; mean ± SD 23 ± 11 23 ± 10 x p= 0.85
Doig 2013 [14] APACHE II score; mean ± SD 20.5 (7.4) x 21.5 (7.8) NR
Heidegger 2013 [15] SAPS II score; mean ± SD x 49 ± 17 47 ± 15 NR
APACHE II score; mean ± SD x 22 ± 7 23 ± 7 NR
Kutsogiannis 2011 [16] APACHE II score; mean ± SD 22.6 ± 8.4 23.3 ± 7.9 22.0 ± 7.9 p= 0.11
Amounts of calories
delivered
Bauer 2000 [11] Enteral intake; mean kcal/kg/day on day 7 14.8 ± 4.6 x 13.2 ± 4.3 p= 0.6
Parenteral intake; mean kcal/kg/day on day 7 9.9 ± 3.1 x 1.1 ± 0.3 p< 0.0001
Total intake; mean kcal/kg/day on day 7 24.6 ± 4.9 x 14.2 ± 6.5 p< 0.0001
Cahill 2011 [12] Enteral intake; mean kcal/kg/day ± SD 5.1 ± 4.9 4.4 ± 3.9 8.8 ± 5.3 p< 0.001†
Parenteral intake; mean kcal/kg/day ± SD 12.0 ± 6.3 8.5 ± 5.9 0 p< 0.001
Total intake; mean kcal/kg/day ± SD 17.5 ± 5.8 13.6 ± 6.3 9.9 ± 5.5 p< 0.001
Casaer 2011 [13] Enteral intake; median kcal/kg/day on day 7,
resp day 8
4 vs 4 6 vs 6 x NR‡
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Table 3 Baseline characteristics (Continued)
Parenteral intake; median kcal/kg/day on
day 7, resp day 8
20 vs 20 3 vs 4 x
Total intake; median kcal/kg/day on day 7 27 vs 26 13 vs 21 x
Doig 2013 [14] Mean kcal/pt/day on day 1, resp day 7 400 vs 1,300 x 0 vs 1,300 NR‡
Heidegger 2013 [15] kcal/kg/day; mean energy delivery between
days 4 and 8 ± SD
x 28 ± 5 20 ± 7 p< 0.0001
Kutsogiannis 2011 [16] Enteral intake; mean kcal/kg/day ± SD 10.2 ± 6.4 7.3 ± 5.1 14.3 ± 6.5 p< 0.001
Parenteral intake; mean kcal/kg/day ± SD 9.0 ± 5.9 7.6 ± 5.9 0 p= 0.02
Total intake; mean kcal/kg/day ± SD 19.5 ± 6.2 15.7 ± 6.1 15.2 ± 6.5 p< 0.001
Amounts of proteins
delivered
Bauer 2000 [11] NR x NR
Cahill 2011 [12] Adequacy of protein (%); mean ± SD 71.5 ± 24.9 53.2 ± 22.7 38.7 ± 21.6 p< 0.001
Casaer 2011 [13] NR NR x
Doig 2013 [14] NR x NR
Heidegger 2013 [15] g/kg/day; mean protein delivery between
day 4 and 8 ± SD
x 1.2 ± 0.2 0.8 ± 0.3 p< 0.0001
Kutsogiannis 2011 [16] Enteral intake; mean g/kg/day ± SD 0.53 ± 0.33 0.47 ± 0.29 0.77 ± 0.35 p< 0.0001
Parenteral intake; mean g/kg/day ± SD 0.63 ± 0.39 0.71 ± 0.40 0 p= 0.48
Total intake; mean g/kg/day ± SD 0.94 ± 0.40 0.77 ± 0.30 0.77 ± 0.35 p< 0.0001
Type of nutrition Bauer 2000 [11] EN: modular polymeric diet: protein (20%), polyunsaturated fats (30%), carbohydrates (50%),
nonsoluble fibers, sodium chloride (2 g/l), potassium chloride (3 g/l) and a standard solution
of hydro- and liposoluble vitamins
PN: 3-in-1 solution of carbohydrates, fat and protein, Vitrimix KV and hydrosoluble vitamins,
Soluvit
Placebo: sodium chloride 0.9% with intralipid 20% (50 ml/l) and Soluvit (10 ml/l)
Cahill 2011 [12] NR
Casaer 2011 [13] EN: mainly Osmolite
EPN: intravenous 20% glucose solution on days 1 and 2. On day 3: PN was initiated
LPN: intravenous 5% glucose solution. On day 8: PN was initiated
PN: trace elements, minerals (potassium, phosphate, magnesium) and vitamins
Doig 2013 [14] Standard care: was defined pragmatically and not via protocol. The attending clinician
selected the route, starting rate, metabolic targets and composition of nutrition.
PN: standard parenteral nutrition from a ready-to-mix three-chamber bag containing
amino acids, glucose, lipids, and electrolytes (Kabiven G19%). Trace elements, minerals
and vitamins were added as clinically appropriate.
Heidegger 2013 [15] EN: polymeric, fibre-enriched formulas, containing 1.05 to 1.62 kcal/ml of energy
(18% proteins, 29% lipids (8% medium-chain triglycerides), 53% carbohydrates)
PN: 0.62 to 1.37 kcal/ml of energy (20% proteins, 29% lipids (15% medium-chain
triglycerides), 51% carbohydrates).
Kutsogiannis 2011 [16] NR
EPN, early parenteral nutrition; LPN, late parenteral nutrition; EN, enteral nutrition; SD, standard deviation; x, not applicable; p, p-value; ns, nonsignificant; NR, not reported;
no, number of patients; %, percentage; kg/m2, weight in kilograms divided by height in meters squared; SAPS II score, simplified acute physiology score; APACHE II score,
score on the Acute Physiology and Chronic Health Evaluation II (range from 0 to 71, with higher scores indicating a greater severity of illness); kcal, kilocalories; kg,
kilograms; resp, respectively; vs, versus; g, grams; PN, parenteral nutrition; l, liters.
NB: studies use different definitions for EPN, LPN and EN. ^, comparing EPN versus EN and EPN versus LPN; *, in this EN group information of 10 patients is missing; †,
comparing EPN versus EN and LPN versus EN; ‡, these are estimated values from a figure, as no values are given.
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Results are shown in Table 9. In one study glucose
control was more strict in the EPN than in the placebo
group (p = 0.0392) [11]. Hypoglycaemia more often oc-
curred in the LPN patients compared with EPN pa-
tients (3.5% versus 1.9%; p = 0.001) in one study [13];however, no differences in hypoglycaemia were found
in another [15].
Muscle wasting and fat loss
Results are shown in Table 9. Doig [14] reported less
muscle wasting (0.43 versus 0.27 score increase per
Table 4 Primary end points in included studies and results for EPN, LPN and EN groups
Primary end points Studies
RCT Prospective observational study
Bauer 2000 [11] Casaer 2011 [13] Doig 2013 [14] Heidegger 2013 [15] Cahill 2011 [12] Kutsogiannis 2011 [16]
ICU length of stay
(median days)
x 3 days (LPN) vs 4 days (EPN); HR
1.06; 95% CI 1.00 to 1.13; p = 0.04
x x x x
Mortality; day 60 x x 22.8% (standard care) vs
21.5% (EPN), RD −1.26%;
95% CI −6.6 to 4.1; p = 0.60
x x x
Nosocomial infection
between days 9 to 28
x x x 27% (EN + LPN) vs 38%
(EN); HR 0.65, 95% CI 0.43




x x x x x EN + EPN vs EN: HR 0.75; 95%
CI 0.59 to 0.96; EN + LPN vs
EN: HR 0.64, 95% CI 0.51 to 0.81
Retinol-binding
protein (RBP)
Significant increase in EN + EPN vs
EN + placebo from day 0 to day 7;
p= 0.0496
x x x x x
Prealbumin Significant increase in EPN vs
placebo (day 0 to day 7);
p= 0.0369
x x x x x
RCT, randomized control trial; ICU, intensive care unit; x, not investigated as a primary end point; LPN, late parenteral nutrition; EPN, early parenteral nutrition; HR, hazard ratio; 95% CI, 95% confidence interval; p,


















Table 5 Mortality end points in included studies and results for EPN, LPN and EN groups
Outcome Study Study arms Significance of results
EPN LPN EN
Mortality in ICU (%) Casaer 2011[13] 6.3 6.1 x p = 0.76
Heidegger 2013 [15] x 0.5 7.0 p = 0.2118
Mortality in hospital (%) Casaer 2011[13] 10.9 10.4 x p = 0.63
Mortality at discharge (%) Casaer 2011[13] 28.3 24.8 x p = 0.007 (discharge from ICU)
Kutsogiannis 2011 [16] NR NR NR EPN vs EN: HR 0.75; 95% CI 0.59
to 0.96; LPN vs EN: HR 0.64, 95%
CI 0.51 to 0.81 (discharge from hospital)
Mortality at day 28 (%) Heidegger 2013 [15] x 13.0 18.0 p = 0.1193
Mortality at day 60 (%) Cahill 2011 [12] 42.2 27.9 34.2 p = 0.17
Kutsogiannis 2011 [16] 34.6 35.3 27.8 p = 0.02†
Mortality at day 90 (%) Bauer 2000 [11] 28.0 x 30.0 no p-value, ns
Casaer 2011[13] 11.2 11.2 x p = 1.00
Mortality at 2 years (%) Bauer 2000 [11] 40.0 x 40.0 no p-value, ns
EPN, early parenteral nutrition; LPN, late parenteral nutrition; EN, enteral nutrition; ICU, intensive care unit; x, not applicable; p, p-value; ns, nonsignificant; NR, not
reported; vs, versus; HR, hazard ratio; 95% CI, 95% confidence interval. NB: studies used different definitions for EPN, LPN and EN. †, comparing EN versus LPN.
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p = 0.01) and fat loss (0.44 versus 0.31 score increase
per week; mean difference −0.13; 95% CI −0.25 to −0.01;
p = 0.04) based on Subjective Global Assessment in the
EPN group compared with standard care.
Discussion
We reviewed relevant studies on early or late SPN in crit-
ically ill adult patients. Results should be interpreted with
caution as study populations differed markedly (medical
versus surgical versus mixed) and often different primary
and secondary end points were addressed. Furthermore,
definitions for early and late SPN varied markedly. For this
reason, we decided not to provide forest plots of results.Table 6 Length of stay end points in included studies and res
Outcome Study Stud
EPN
ICU length of stay Bauer 2000 [11] Mean days 16.9
Doig 2013 [14] Mean days 8.6
Heidegger 2013 [15] Mean days x
Cahill 2011 [12] Median days 15
Kutsogiannis 2011 [16] Median days 13.9
Hospital length of stay Bauer 2000 [11] Mean days 31.2
Casaer 2011 [13] Median days 16
Doig 2013 [14] Mean days 25.4
Heidegger 2013 [15] Mean days x
Cahill 2011 [12] Median days 47.6
Kutsogiannis 2011 [16] Median days 33.4
EPN, early parenteral nutrition; LPN, late parenteral nutrition; EN, enteral nutrition; I
difference; HR, hazard ratio; 95% CI, 95% confidence interval. NB: studies used diffe
comparing LPN versus EN. ^, comparing EN versus LPN.Mortality
Mortality rates at various end points showed no signifi-
cant differences between EPN and LPN groups. Follow-
up duration in the selected studies varied from 28 days
until 2 years. This may have resulted in incorrect lower
ICU or hospital mortality rates in studies with shorter
follow-ups, as some patients still may have been hospi-
talized at day 28. However, early SPN does not show to
reduce mortality.
Morbidity
Commencing early PN does not result in benefits in
ICU or hospital length of stay. Duration of renal replace-
ment therapy may increase by EPN. Effects on durationults for EPN, LPN and EN groups
y arms Significance of results
LPN EN
± 11.8 x 17.3 ± 12.8 no p-value, ns
x 9.3 RD −0.75 (−1.47 to 0.04); p = 0.06
13 13 p = 0.2592
22.1 12.4 p < 0.001†
18.3 11.7 p = 0.003^
± 18.5 x 33.7 ± 27.7 p = 0.0022
14 x HR 1.06; 95% CI 1.00 to 1.13; p = 0.04.
x 24.7 RD 0.7; 95% CI −1.4 to 3.1; p = 0.50
31 32 p = 0.8781
35 24.8 p < 0.001
35.3 27.1 p = 0.004
CU, intensive care unit; x, not applicable; p, p-value; ns, nonsignificant; RD, risk
rent definitions for EPN, LPN and EN. †, comparing EPN versus EN and
Table 7 Infection end points in included studies and results for EPN, LPN and EN groups
Outcome Study Study arms Significance of results
EPN LPN EN
Infections (%) Bauer 2000 [11] 47.0 x 38.0 Respiratory infections: no p-value, ns
Bauer 2000 [11] 18.0 x 27.0 UTI: no p-value, ns
Casaer 2011 [13] 26.2 22.8 x p = 0.008
Doig 2013 [14] NR x NR No significant differences between standard
care or EPN
Antibiotic (mean days ± SD) Heidegger 2013 [15] x 5 ± 7 6 ± 7 p = 0.0298
Antibiotic free (mean days ± SD) Heidegger 2013 [15] x 15 ± 9 13 ± 10 p = 0.0126†
EPN, early parenteral nutrition; LPN, late parenteral nutrition; EN, enteral nutrition; p, p-value; ns, nonsignificant; UTI, urinary tract infections; NR, not reported; SD,
standard deviation. NB: studies used different definitions for EPN, LPN and EN. †, analyses performed between day 9 and day 28.
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showed that EPN resulted in significantly fewer days of
invasive ventilation; however, the mean reduction of
ventilation duration was only 0.47 days and could not be
translated into a significantly shorter ICU or hospital
length of stay. In contrast, Casaer showed that more pa-
tients needed prolonged ventilation in the EPN group [13].
Infections reported after randomization were either
nonsignificant or increased during EPN. The lower num-
ber of antibiotic days and more antibiotic-free days in
the EPN group versus the LPN group in the study by
Heidegger may be explained by either a lower total
number of infections reported in the EPN group or only
reporting infections after day 9 (and randomization
occurred at day 3). Early SPN does not reduce infectious
morbidity and even seems to increase infection rates.
Nutritional intake, metabolic consequences and effects on
body composition
Three studies examined the energy, calorie and protein
delivery [12,15,16] and found that PN promotes reach-
ing energy and protein targets. Within the PN groups,
EPN resulted in more optimal intake of calories and
proteins, suggesting better feeding adequacy compared
with LPN. Strikingly, these findings do not translate
into marked differences in end points.Table 8 Nutritional adequacy in included studies and results
Outcome Study S
E
Adequacy of calories (mean% ± SD) Cahill 2011 [12] 7
Kutsogiannis 2011 [16] 8
Adequacy of proteins (mean% ± SD) Cahill 2011 [12] 7
Kutsogiannis 2011 [16] 8
Mean energy delivery (kcal/kg/d ± SD; %
of energy target ± SD)
Heidegger 2013 [15] x
EPN, early parenteral nutrition; LPN, late parenteral nutrition; EN, enteral nutrition; %
d, day; x, not applicable. NB: studies used different definitions for EPN, LPN and EN.
EPN versus LPN; ^, analyses between day 4 and day 8.Effects on glucose regulation and incidence of
hypoglycaemia were not consistent. Other studies have
demonstrated clearly that parenteral nutrition negatively
affects insulin sensitivity and that parenteral-nutrition-
induced hyperglycaemia is associated with increased mor-
bidity and mortality [20].
One study reported EPN to be protective against both
muscle wasting and fat loss. Although this might be
expected to translate into improved recovery of physical
function, mortality and length of stay obtained 60 days
after enrolment did not differ between groups [14].
Meanwhile, a preplanned substudy of the EPaNIC study
showed that early parenteral nutrition did not prevent
the wasting of skeletal muscle in critical illness and in-
creased the amount of adipose tissue within the muscle
compartments [21].
Economic consequences
In general, acquisition costs for parenteral nutrition are
higher compared with enteral nutrition [11,22].
Doig and co-workers showed a small reduction in dur-
ation of mechanical ventilation in patients on EPN [23].
This incurred lower costs estimated at US$3,150 per pa-
tient (95% confidence interval US$1,314 to US$4,990)
[23]. In contrast, Casaer and co-workers showed signifi-
cantly higher expenditures up to a mean total cost increasefor EPN, LPN and EN groups
tudy arms Significance
of resultsPN LPN EN
4.1 ± 21.2 57.4 ± 22.7 42.9 ± 21.2 p < 0.001†
1.2 ± 23.1 64.3 ± 20.6 63.4 ± 23.4 p < 0.0001†
1.5 ± 24.9 53.2 ± 22.7 37.8 ± 21.6 p < 0.001†
0.1 ± 30.3 59.9 ± 21.2 59.3 24.3 p < 0.0001†
28 ± 5; 103 ± 18 20 ± 7; 77 ± 27 p < 0.0001^
, percentage, SD, standard deviation; p, p-value; kcal, kilocalorie; kg, kilogram;
†, comparing EPN versus EN and comparing LPN versus EN and comparing
Table 9 Remaining secondary end points in included studies and results for EPN, LPN and EN groups




Bauer 2000 [11] Mean days 11 ± 9 x 10 ± 8 no p-value, ns
Casaer 2011 [13] Median days 2 2 x p = 0.02
Duration >2 days 40.2% 36.3% x p = 0.006; in LPN 9.7%
relative reduction in
mechanical ventilation
in patients requiring ≥2 days
mechanical ventilation
Doig 2013 [14] NR x NR EPN: 1.07 fewer days than
standard care.
Mean days per 10 patients x
ICU days
7.73 x 7.26 MD −0.47; 95% CI −0.82
to −0.11; p = 0.01)





Cahill 2011 [12] Median days 8.8 18.2 9.3 p < 0.001†
Kutsogiannis 2011 [16] Median days 9.1 14.5 8.4 p = 0.007^
Hypoglycaemia Bauer 2000 [11] Mean glucose in grams per
liter at day 7 (±SD)
1.16 ± 0.56 x 1.31 ± 0.62 p < 0.05
Casaer 2011 [13] Number of patients (%) 45 (1.9) 81 (3.5) x p = 0.001
Heidegger 2013 [15] NR x NR NR No difference between
EN + LPN vs EN
Duration of RRT Bauer 2000 [11] Mean days (±SD) 0.8 (±2.4) x 0.9 (±2.3) No p-value, ns
Casaer 2011 [13] Median days 10 7 x p =0.008
Heidegger 2013 [15] x NR NR No difference between
EN + LPN vs EN
Body composition
(score increase/week)
Doig 2013 [14] Increased SGA score/week 0.43 x 0.27 MD −0.16; 95% CI −0.28
to −0.038; p = 0.01
Increased SGA score/week 0.44 x 0.31 MD −0.13; 95% CI −0.25
to −0.01; p = 0.04
EPN, early parenteral nutrition; LPN, late parenteral nutrition; EN, enteral nutrition; x, not applicable; p, p-value; ns, nonsignificant; NR, not reported; ICU, intensive
care unit; MD, mean difference; 95% CI, 95% confidence interval; vs, versus; RRT, renal replacement therapy; SD, standard deviation; SGA, Subjective Global
Assessment. NB: studies used different definitions for EPN, LPN and EN. †, comparing EPN versus EN and comparing LPN versus EN. ^, comparing EN versus LPN.
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ating the full PN costs. This was mainly due to the acquisi-
tion costs of PN and anti-infective medications [24].
We believe that a reasonable interpretation of the
present evidence is that EPN in adult critically ill pa-
tients does not confer clinically relevant benefits com-
pared to LPN with respect to morbidity and mortality
end points. Some studies report small benefits, others
no effect or even increased morbidity.
Patients that reach energy and protein targets by the
enteral route show better outcomes than patients that
did not [25,26], whereas reaching these targets through
addition of PN seems to provide different and potentially
less beneficial effects. Clearly, providing calories and
proteins through EN or PN induces divergent effects.
At present, it is unclear which factors induce the nega-
tive pathophysiological effects of early administration of
PN that counterbalance the beneficial effect of a more
optimal nutritional intake with respect to calories and
proteins. Potentially, SPN may interfere with the earlyinflammatory response present in most ICU patients.
Among negative effects, autophagy has been suggested.
Autophagy is the basic catabolic mechanism that
involves cell degradation of unnecessary or dysfunctional
cellular components through the actions of lysosomes. A
planned subanalysis of the EPaNIC trial [27] found that
tolerating a substantial macronutrient deficit early dur-
ing a critical illness did not affect muscle wasting but
allowed more efficient activation of autophagic quality
control of myofibres and reduced weakness. Thus, SPN
may hamper the autophagy phenotype. The role of
autophagy prevention in critically ill patients has to be
determined in the future. Other suggestive negative
effects of SPN are increased risk of overfeeding and
refeeding, fat overload, glucose intolerance and immune-
modulating effects of lipids [28].
Study limitations
Several limitations in the selected studies were found.
Two studies [12,16] were not randomized controlled
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ment was not blinded and we found statistically signifi-
cant differences in baseline characteristics. Furthermore,
results were based on partly overlapping study groups.
In the Cahill study [12], all surgical patients were
excluded to select a more homogenous study population,
as surgical patients typically are more difficult to feed,
have lower tolerance to EN, and receive less nutrition
compared to medical patients. This reduces external val-
idity for surgical ICU patients. Furthermore, both groups
receiving PN (EPN versus LPN) were relatively small
potentially causing insufficient power to detect clinically
relevant differences.
The study by Heidegger and co-workers [15] was heav-
ily criticized for performing analyses on new infections
between days 9 and 28, whereas randomization occurred
on day 3. The registered protocol indicated that the pri-
mary outcome was the infection rate in the first 28 days,
not just between day 9 and day 28. SPN was provided
on day 4, and the SPN group had more total infectious
events between day 4 and day 8 (34% [52/153] versus
28% [43/152]). Total infections between day 4 and day
28 appear quite similar (114 versus 100). Selective out-
come bias seems to be present [17-19].
Then, the authors state that 25 to 30 kcal/kg per day
was the target for adequate energy intake. But control
patients received only 20 kcal/kg per day, potentially in-
creasing the risk of underfeeding-related complications,
such as infections. The intervention group, which re-
ceived 28 kcal/kg per day through enteral nutrition plus
10 kcal/kg per day parenterally, showed a significantly
lower rate of infections compared with the control group
receiving 20 kcal/kg per day. The authors conclude in
favour of the parenteral supplementation; however, ob-
served differences might be only related to a higher cal-
orie intake [29].
The study performed by Doig [14] was prematurely
terminated for financial reasons. This has changed the
period of follow-up and therefore might have influenced
the presented results.
Finally, in the study by Casaer [13], almost 90% of the
patients studied were surgical patients, the majority of
whom (58.5%) appeared to be admitted electively. Study
patients remained in the ICU for a limited time, with
more than 70% of subjects averaging only a 3- to 4-day
length of stay. These patients were only moderately
severely ill, with an 8% ICU mortality. Therefore, this
could suggest that external validity for critically ill pa-
tients with higher severity of illness and medical patients
is limited; however, a post-hoc sensitivity analysis ad-
dressing the effects of severity of illness did not impact
on the reported results [30]. Furthermore, it is hard to
attribute all adverse events in this study to early PN,
when the majority of study patients received limitedexposure to early PN and more than 70% of the late PN
group did not receive PN at all. It is therefore conceiv-
able that benefits of late PN were seen because the ma-
jority of patients received no PN or early high-glucose
loading. Patients randomized to the EPN group received
glucose 20% at 40 ml/h on the admission day, in con-
trast to patients randomized to the LPN group. They
received a volume of glucose 5% that was required to
obtain adequate hydration taking into account the vol-
ume of EN that was being delivered [31]. In addition, all
patients in both groups were managed by tight glucose
control, using the protocol reported by Van den Berghe
[32,33]. This concept of tight glucose control has subse-
quently been shown to be ineffective and potentially
harmful [34]. It is unclear how this glucose loading and
tight glucose regulation strategy impact on the reported
effects of early and late SPN.
Other methodological issues may have influenced
reported results such as incorrect interpretation of data
due to inappropriate censoring for time-to-event ana-
lyses when the duration of follow-up is not identical for
all subjects. This could be relevant for end points such
as ICU and hospital length of stay or hospital mortality.
This problem can be circumvented by reporting land-
mark time-to-event analysis (for example, 180-day mor-
tality) in all patients [35]. As this has not been done in
many studies, inappropriate censoring may be present
and may invalidate reported data.
Strengths of this systematic review are the large number
of patients studied in the selected studies (n = 10,060) and
the structured analysis and appraisal of the available
literature.
However, several limitations of this systematic review
also have to be mentioned. Definitions of EPN and LPN
are different among studies. When the ‘early’ period
stops and the ‘late’ period starts is not defined. Late may
be considered at the end of the first week [36]. Further-
more, the study design, year of patient inclusion and
primary and secondary end point variations may affect
interpretation of overall results. Moreover, insufficient
information is available on vitamins, trace elements and
parenteral lipids used.
Conclusions
In adult critically ill patients, when full enteral nutrition
support is not possible or fails to reach caloric targets,
early administration of supplemental parenteral nutrition
compared with late administration (at the end of the first
week after ICU admission) does not confer major bene-
fits with respect to morbidity and mortality. However,
considering that infectious morbidity and resolution of
organ failure may be negatively affected through mecha-
nisms not yet clearly understood and acquisition costs of
parenteral nutrition are higher compared with enteral
Bost et al. Annals of Intensive Care 2014, 4:31 Page 12 of 13
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cannot be recommended. Additional research is war-
ranted to recommend the optimal timing of SPN in crit-
ically ill adults.
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